Inhibitors of the mTOR signaling pathway can play an important role in breast cancer immunopathogenesis
Article in Cell Biology International (August 2024)
The most recent citing publications are shown below. View all 206 publications that cite this research output on Dimensions.
SYT7 promotes breast cancer cells growth through the PI3K/AKT pathway
Article in Translational Cancer Research (June 2024)
Efficacy and Safety of AKT Inhibitors in HR+/HER2- Breast Cancer or Metastatic TNBC: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Preprint in Research Square (April 2024)